Boardroom Alpha
10-K primary document
SBC · Annual Report (Form 10-K) · Filed March 27, 2026

Sbc Medical Group Holdings Inc10-K exhibit

sbc-ex21_1.htm
EX-21.1

Exhibit 21.1

List of Subsidiaries of the Registrant

 

Name of Entity

 

Relationship with Registrant

 

Jurisdiction of Incorporation or Organization

SBC Medical Group, Inc.

 

Subsidiary

 

Delaware

SBC Medical Group Co., Ltd.

 

Subsidiary

 

Japan

Liesta Co., Ltd.

 

Subsidiary

 

Japan

SBC Sealane Co., Ltd.

 

Subsidiary

 

Japan

SBC Marketing Co., Ltd.

 

Subsidiary

 

Japan

SBC Medical Consulting Co., Ltd.

 

Subsidiary

 

Japan

MB career lounge Co., Ltd.

 

Subsidiary

 

Japan

Shoubikai Medical Vietnam Co., Ltd.

 

Subsidiary

 

Vietnam

SBC Healthcare, Inc.

 

Subsidiary

 

Delaware

SBC Irvine, LLC

 

Subsidiary

 

Delaware

Aesthetic Healthcare Holdings Pte. Ltd.

 

Subsidiary

 

Singapore

Wen & Weng Family Clinic Pte. Ltd.

 

Subsidiary

 

Singapore

Wen & Weng Medical Group Pte. Ltd.

 

Subsidiary

 

Singapore

Rochor Clinic Pte. Ltd.

 

Subsidiary

 

Singapore

Dermasolutions Pte. Ltd.

 

Subsidiary

 

Singapore

Dermasolutions Services Pte. Ltd.

 

Subsidiary

 

Singapore

SBC MEDICAL APAC PTE. LTD.

 

Subsidiary

 

Singapore

Medical Payment Co., Ltd.

 

Majority owned subsidiary

 

Japan

Waqoo, Inc.

 

Majority owned subsidiary

 

Japan

Cell Pro Japan Co., Ltd.

 

Majority owned subsidiary

 

Japan

Aikawa Medical Management, Inc.

 

Variable interest entity

 

California

 


Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer